CVS Health Corporation (NYSE:CVS) is expected to pay $0.43 on Nov 3, 2016. The indicated annual dividend is $1.70. Shareholders owning the stock before Oct 20, 2016 will be eligible to receive the payout. Based on CVS Health Corporation’s current price of $87.19, the dividend is 0.49%. This dividend’s record date is Oct 24, 2016 and the announcement date is Sep 22, 2016. The stock increased 0.61% or $0.53 during the last trading session, hitting $87.19. CVS Health Corp (NYSE:CVS) has declined 13.66% since March 16, 2016 and is downtrending. It has underperformed by 19.20% the S&P500.
CVS Health Corporation, together with its subsidiaries , is a pharmacy company. The company has a market cap of $90.72 billion. The Firm operates through three business divisions: Pharmacy Services, Retail/LTC and Corporate. It has a 20.07 P/E ratio. The Firm offers a range of services and products, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.
Insitutional Activity: The institutional sentiment decreased to 1 in Q2 2016. Its down 0.10, from 1.1 in 2016Q1. The ratio is negative, as 67 funds sold all CVS Health Corp shares owned while 574 reduced positions. 97 funds bought stakes while 544 increased positions. They now own 833.68 million shares or 6.91% less from 895.55 million shares in 2016Q1.
Interest Value Advisers Limited Liability Company holds 1.22 million shares or 3.45% of its portfolio. Boston Management Inc holds 1.67% of its portfolio in CVS Health Corp (NYSE:CVS) for 28,790 shares. Buckhead Cap Ltd holds 1.76% or 101,261 shares in its portfolio. Boston Private Wealth Lc has 1.2% invested in the company for 307,408 shares. Ig Inv last reported 848,909 shares in the company. Folger Nolan Fleming Douglas Capital last reported 8,358 shares in the company. Td Asset Incorporated accumulated 0.29% or 1.66M shares. United Financial Advisers Ltd Liability Co has 0.08% invested in the company for 78,290 shares. Gideon Cap owns 8,026 shares or 0.45% of their US portfolio. Dumont Blake Invest Advisors Ltd Liability accumulated 0.86% or 16,122 shares. Moreover, Atlanta Capital Management L L C has 1% invested in CVS Health Corp (NYSE:CVS) for 1.56M shares. Moreover, Country Club Tru Na has 0.83% invested in CVS Health Corp (NYSE:CVS) for 59,630 shares. Janney Montgomery Scott Ltd Llc holds 398,743 shares or 0.61% of its portfolio. Windward Mgmt Ca holds 379,425 shares or 7.04% of its portfolio. Fifth Third Bancorp reported 824,075 shares or 0.67% of all its holdings.
Insider Transactions: Since May 5, 2016, the stock had 0 buys, and 3 insider sales for $5.83 million net activity. On Thursday, May 5 the insider Brennan Troyen A sold $789,285. 38,247 CVS Health Corp (NYSE:CVS) shares with value of $4.02M were sold by MERLO LARRY J. 9,798 shares with value of $1.03 million were sold by GOLD STEPHEN J on Thursday, May 5.
CVS Health Corp (NYSE:CVS) Ratings Coverage
Out of 15 analysts covering CVS Health (NYSE:CVS), 11 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 73% are positive. $132 is the highest target while $104 is the lowest. The $116.27 average target is 33.35% above today’s ($87.19) stock price. CVS Health has been the topic of 22 analyst reports since July 22, 2015 according to StockzIntelligence Inc. The stock of CVS Health Corp (NYSE:CVS) earned “Outperform” rating by RBC Capital Markets on Wednesday, August 5. Oppenheimer maintained the shares of CVS in a report on Friday, August 28 with “Outperform” rating. The rating was maintained by S&P Research on Monday, November 2 with “Strong Buy”. The firm has “Buy” rating given on Thursday, October 6 by UBS. Deutsche Bank maintained it with “Hold” rating and $117 target price in Wednesday, July 22 report. Deutsche Bank maintained the stock with “Hold” rating in Thursday, August 20 report. The stock has “Overweight” rating given by Barclays Capital on Friday, December 18. Vetr upgraded the shares of CVS in a report on Monday, August 24 to “Buy” rating. On Thursday, December 17 the stock rating was maintained by Oppenheimer with “Outperform”. The firm has “Neutral” rating by Goldman Sachs given on Thursday, December 17.
More notable recent CVS Health Corp (NYSE:CVS) news were published by: Forbes.com which released: “January 2019 Options Now Available For CVS Health (CVS)” on October 17, 2016, also Seekingalpha.com with their article: “Why I Am Now Interested In CVS Health Corporation” published on October 13, 2016, Schaeffersresearch.com published: “Analyst Downgrades: CVS Health Corp, Dunkin Brands Group Inc, and Twitter Inc” on October 17, 2016. More interesting news about CVS Health Corp (NYSE:CVS) were released by: Benzinga.com and their article: “Jim Cramer On CVS Health Corp And Skechers USA Inc” published on September 25, 2016 as well as Law360.com‘s news article titled: “CVS Health Slapped With Infringement Suit Over Heart Logo” with publication date: September 21, 2016.
CVS Company Profile
CVS Health Corporation, incorporated on August 22, 1996, together with its subsidiaries (CVS Health), is a pharmacy company. The Firm operates through three business divisions: Pharmacy Services, Retail/LTC and Corporate. The Firm offers a range of services and products, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions. The Retail Pharmacy segment includes retail drugstores, online retail pharmacy Websites and its retail healthcare clinics.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.